{
    "clinical_study": {
        "@rank": "161583", 
        "arm_group": {
            "arm_group_label": "CGM System", 
            "arm_group_type": "Experimental", 
            "description": "Single-Arm, CGM Device"
        }, 
        "brief_summary": {
            "textblock": "To establish the performance of the Dexcom G4 Platinum with a Modified Algorithm continuous\n      monitoring system when compared to a laboratory reference measurement."
        }, 
        "brief_title": "Effectiveness and Safety Study of the Dexcom G4 Platinum With Modified Algorithm", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Diabetes Mellitus", 
        "condition_browse": {
            "mesh_term": "Diabetes Mellitus"
        }, 
        "detailed_description": {
            "textblock": "A study to evaluate the performance of a modification to the G4 Platinum CGM system in\n      adults with diabetes."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Ages 18 years or older\n\n          -  Diagnosis of Type 1 diabetes or Type 2 diabetes on Intensive Insulin Therapy (ITT)\n\n          -  Willing to participate in a clinic session\n\n        Exclusion Criteria:\n\n          -  Use of Acetaminophen during study period\n\n          -  Pregnancy\n\n          -  Hematocrit (HCT) <35% (females) and 38% (males)\n\n          -  Dialysis, history of cardiovascular disease, epilepsy, severe migraines in the past 6\n             months, adrenal disease, syncope, significant hypoglycemia unawareness, or a history\n             of severe hypoglycemia within the last 6 months.\n\n          -  Any condition that, in the opinion of the Investigator, would interfere with their\n             participation in the study or pose and excessive risk to study staff."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "54", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 3, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02087995", 
            "org_study_id": "PTL901100"
        }, 
        "intervention": {
            "arm_group_label": "CGM System", 
            "description": "A prescribed clinic session day for participating subjects.", 
            "intervention_name": "Continuous Glucose Monitoring", 
            "intervention_type": "Device", 
            "other_name": [
                "CGM System", 
                "G4 Platinum CGM System", 
                "Dexcom G4 CGM System"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "Diabetes Mellitus", 
        "lastchanged_date": "March 12, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Concord", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94520"
                    }, 
                    "name": "John Muir Physician Network Clinical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Escondido", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92026"
                    }, 
                    "name": "AMCR Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Walnut Creek", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94598"
                    }, 
                    "name": "Diablo Clinical Research, Inc."
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Effectiveness and Safety Study of the Dexcom G4 Platinum With Modified Algorithm", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "the proportion of System values that are within 20% of the reference value for YSI glucose levels > 80 mg/dL or within 20 mg/dL at the reference glucose levels < 80 mg/dL.", 
            "measure": "The percentage of agreement of the System compared to a laboratory reference measurement.", 
            "safety_issue": "No", 
            "time_frame": "7-day wear period"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02087995"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "DexCom, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "DexCom, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Single Blind (Subject)", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}